Holliston, MA – Digilab, Inc. announces the introduction of the CellJet Cell Printer for Live Cell Printing for High Content Analysis & Cell Assays. The CellJet utilizes Digilab’s proprietary Contamination-Free, Non-Contact synQUAD Dispensing technology offering both on-the-fly and drop-by-drop non-contact cell printing while maintaining the viability of even the most delicate cells. This CellJet offers users full control over critical dispense parameters such as height of dispense and dispensing speed, which allows printing of both viscous solutions and fragile cells.

The Digilab CellJet prints into plates or onto slides using a valve-free fluid path, which greatly reduces cell damage. The CellJet Cell Printer also includes full wash capability, an easy-to-clean and sterilize evaporation cover, and an effective instrument design for hassle-free maintenance. Cells are aspirated from their source through ceramic tips into coiled tubing and dispensed into microtiter plates or slides without making contact with any valve. The CellJet offers the ability to dispense a droplet anywhere within a microtiter plate or to multiplate droplets spatially within a single cell.

About Digilab, Inc.

Digilab; a global leader in molecular spectroscopy systems for over 40 years focusing on sample preparation, bioinformatics, and detection/analysis tools enabling solutions for the life sciences research and in-vitro diagnostics markets, including pharmaceutical and biotech industries, as well universities and governments.

In September of 2004, Digilab sold its product assets to Varian Inc., Digilab, Inc invested the proceeds of this transaction in a business model focused principally on life science research tools and downstream point of need clinical, safety and security applications.

In June of 2006, Digilab acquired SpectraCode Inc. in West Lafayette, Indiana. This acquisition provides Digilab core competence and products in high growth applications which require the versatility and ease of use of Raman Molecular Spectroscopy.

In November of 2007, Digilab acquired Genomic Solutions (which included Gene Machines, Cartesian, and BioRobotics) and MAIA Scientific. These acquisitions broaden Digilab’s global footprint in both the Life Sciences Research pre-analytics market and its commitment to provide downstream systems and solutions which will have broad application in clinical diagnostics.

Digilab, via a series of acquisitions and partnerships, is implementing this business model. Its vision and strategy is retention/expansion of market awareness as a company with unique and high value products for principally the health sciences markets